Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Car
Go back to Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Car| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 0.88 +0.01 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $3.65 | |||
| Open | $0.87 | 52 Week Low | $1.24 | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.87 | EPS | $0.00 | |||
| Volume | 764,046 | |||||
